Developer docs
API playgroundTry for free, no card

Search company profiles

FEMME

Full company profile

uuid000etnj

Namestring
FEMME
Legal namestring
FEMME
Company typeenum
Private
Founded yearint
1983
Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersSão Paulo, Brazil
HQ citystring
São Paulo
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
women's diagnostic services, gynecology diagnostics, breast imaging, fetal medicine, clinical pathology labs
Industry2 codes
1Obstetrics & Gynecology (OB/GYN) Clinics
CodeHLAFAJAAPrimaryYes
2Women’s Imaging & Breast Health Centers
CodeHLAFAJAJPrimaryNo
NAICS code3 codes
  • Offices of Physicians62111
  • Medical and Diagnostic Laboratories6215
  • Diagnostic Imaging Centers621512
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Medical Laboratories8071
Product category
Women's Health Diagnostic Laboratory Services
Social media profiles1 record
Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

FEMME provides specialized women's health diagnostic services including gynecology diagnostics, ultrasound, fetal medicine, breast imaging, genetics testing, pathology laboratory services, and blood tests. The company operates as a women's health-focused laboratory serving individual female patients with targeted diagnostic offerings.

Differentiator
Functional benefit
Problem solved
Product and service6 records
1Gynecology Diagnostics
CategoryWomen's Diagnostics
Description

Diagnostic gynecological services for women, including clinical evaluations and testing related to reproductive and gynecological health.

2Ultrasound Diagnostics
CategoryDiagnostic Imaging
Description

Ultrasound imaging services for women's health assessments.

3Fetal Medicine
CategoryWomen's Diagnostics
Description

Fetal medicine diagnostic services for monitoring and assessing fetal health during pregnancy.

4Breast Imaging
CategoryDiagnostic Imaging
Description

Breast imaging diagnostic services for women, supporting early detection and evaluation of breast health conditions.

5Genetics Testing
CategoryClinical Laboratory
Description

Genetic testing services targeted at women's health diagnostics.

6Pathology Laboratory and Blood Tests
CategoryClinical Laboratory
Description

Pathology laboratory analyses and blood tests performed for diagnostic purposes for women patients.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Brazilian clinical diagnostics and imaging network with broad lab, ultrasound and women's health services. Directly comparable in service mix, payor relationships, and B2B screening offerings.

TypeBroad incumbent
Description

Parent company of FEMME and the largest diagnostics platform in Brazil. Directly comparable as a medical diagnostics, imaging and lab operator serving the same patient, physician and payor ecosystem across Brazil.

TypeBroad incumbent
Description

European medical diagnostics provider with broad clinical lab and imaging operations. Comparable as a multi-country diagnostics platform benchmark for scale, footprint and women's health strategy.

TypeBroad incumbent
Description

Brazilian tertiary hospital system with affiliated diagnostics, imaging and women's health services. Comparable premium positioning and São Paulo patient base.

TypeBroad incumbent
Description

Large US diagnostics incumbent with extensive imaging, lab and women's health offerings. Useful comparable for unit economics, payor contracting models, and operational benchmarks.

TypeDirect peer
Description

São Paulo-based diagnostic medicine brand under DASA, offering imaging, clinical analysis and gynecology diagnostics. Same metro footprint and comparable women's health service mix.

TypeDirect peer
Description

Brazilian diagnostic medicine group with clinical analysis labs, imaging and women's health services. Closely comparable business model and target patient segments to FEMME.

TypeDirect peer
Description

Brazil's largest medical diagnostics company, operating imaging centers, clinical labs and pathology services. Directly competes with FEMME for patients, physicians and payor contracts across women's health and broader diagnostics.

TypeBroad incumbent
Description

Global clinical laboratory and diagnostics network. Comparable in core lab and pathology capabilities, women's health panels, and physician-office relationships.

TypeEmerging player
Description

Brazilian digital diagnostics startup offering remote point-of-care lab testing. Emerging competitor bringing tech-enabled, decentralized diagnostics to the same patient segments FEMME serves.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

FEMME

Women's Health Diagnostic Laboratory Serviceslaboratoriodamulher.com.br

FEMME firmographics

Firmographics
Name
FEMME
Legal name
FEMME
Website
https://laboratoriodamulher.com.br
Company type
Private
Founded year
1983
Operating status
Acquired
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

FEMME industry classification

Industry
Product category
Women's Health Diagnostic Laboratory Services
NAICS
Offices of Physicians (62111), Medical and Diagnostic Laboratories (6215), Diagnostic Imaging Centers (621512)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071)
akta.pro primary industry
Obstetrics & Gynecology (OB/GYN) Clinics (HLAFAJAA)
akta.pro secondary industry
Women’s Imaging & Breast Health Centers (HLAFAJAJ)

Keywords

  • Women's diagnostic services
  • Gynecology diagnostics
  • Breast imaging
  • Fetal medicine
  • Clinical pathology labs

Where FEMME is headquartered

Location

Headquarters

HQ city
São Paulo
HQ country
Brazil
HQ region
Latin America

Offices1 record

Markets served

FEMME business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

FEMME product offering

Product offering

Core offering

FEMME provides specialized women's health diagnostic services including gynecology diagnostics, ultrasound, fetal medicine, breast imaging, genetics testing, pathology laboratory services, and blood tests. The company operates as a women's health-focused laboratory serving individual female patients with targeted diagnostic offerings.

Differentiator

Problem solved

Functional benefit

Products and services

  • Gynecology Diagnostics Diagnostic gynecological services for women, including clinical evaluations and testing related to reproductive and gynecological health.
  • Ultrasound Diagnostics Ultrasound imaging services for women's health assessments.
  • Fetal Medicine Fetal medicine diagnostic services for monitoring and assessing fetal health during pregnancy.
  • Breast Imaging Breast imaging diagnostic services for women, supporting early detection and evaluation of breast health conditions.
  • Genetics Testing Genetic testing services targeted at women's health diagnostics.
  • Pathology Laboratory and Blood Tests Pathology laboratory analyses and blood tests performed for diagnostic purposes for women patients.

Companies that use FEMME

Customer profile

Segments1 record

Ideal customer profiles1 record

FEMME technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

FEMME partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights3 records

FEMME competitors and assessment

Company assessment

Direct peers

  • Hermes Pardini: Brazilian clinical diagnostics and imaging network with broad lab, ultrasound and women's health services. Directly comparable in service mix, payor relationships, and B2B screening offerings.
  • Delboni Auriemo: São Paulo-based diagnostic medicine brand under DASA, offering imaging, clinical analysis and gynecology diagnostics. Same metro footprint and comparable women's health service mix.
  • Sabin Diagnósticos e Saúde: Brazilian diagnostic medicine group with clinical analysis labs, imaging and women's health services. Closely comparable business model and target patient segments to FEMME.
  • Diagnósticos da América (DASA): Brazil's largest medical diagnostics company, operating imaging centers, clinical labs and pathology services. Directly competes with FEMME for patients, physicians and payor contracts across women's health and broader diagnostics.

Broad incumbents

  • Fleury: Parent company of FEMME and the largest diagnostics platform in Brazil. Directly comparable as a medical diagnostics, imaging and lab operator serving the same patient, physician and payor ecosystem across Brazil.
  • SYNlab: European medical diagnostics provider with broad clinical lab and imaging operations. Comparable as a multi-country diagnostics platform benchmark for scale, footprint and women's health strategy.
  • Hospital Israelita Albert Einstein: Brazilian tertiary hospital system with affiliated diagnostics, imaging and women's health services. Comparable premium positioning and São Paulo patient base.
  • Quest Diagnostics: Large US diagnostics incumbent with extensive imaging, lab and women's health offerings. Useful comparable for unit economics, payor contracting models, and operational benchmarks.
  • Labcorp: Global clinical laboratory and diagnostics network. Comparable in core lab and pathology capabilities, women's health panels, and physician-office relationships.

Emerging players

  • Hilab: Brazilian digital diagnostics startup offering remote point-of-care lab testing. Emerging competitor bringing tech-enabled, decentralized diagnostics to the same patient segments FEMME serves.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

FEMME social profiles

Digital presence

FEMME financial estimates

Financial estimate

Revenue estimate

Valuation estimate

FEMME leadership team

Management profile

Number of profiles

FEMME funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

FEMME M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FEMME

What does FEMME do?

FEMME provides specialized women's health diagnostic services including gynecology diagnostics, ultrasound, fetal medicine, breast imaging, genetics testing, pathology laboratory services, and blood tests. The company operates as a women's health-focused laboratory serving individual female patients with targeted diagnostic offerings.

Is FEMME a public or private company?

FEMME is a private company. It is classified as corporate owned and is currently acquired.

When was FEMME founded?

FEMME was founded in 1983. It employs 1,001 to 5,000 people.

Where is FEMME based?

FEMME is headquartered in São Paulo, Brazil, in the Latin America region.

Who are FEMME's main competitors?

Direct peers on record are Hermes Pardini, Delboni Auriemo, Sabin Diagnósticos e Saúde and Diagnósticos da América (DASA). Broad incumbents are Fleury, SYNlab, Hospital Israelita Albert Einstein, Quest Diagnostics and Labcorp. Hilab is listed as an emerging player.

Does FEMME have an API?

No public API is recorded for FEMME.

What industry is FEMME in?

FEMME's product category is Women's Health Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAJAA, Obstetrics & Gynecology (OB/GYN) Clinics, with a secondary code of HLAFAJAJ, Women’s Imaging & Breast Health Centers. Its NAICS code is 62111 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FolhaFleury tem lucro 45,7% maior no segundo trimestre e mantém aquisições no radarO Grupo Fleury registrou alta de 45,7% no lucro líquido, atingindo R$ 221,8 milhões, e crescimento de 14,4% na receita bruta, que chegou a R$ 2,5 bilhões no segundo trimestre, superando as expectativas dos analistas. A companhia impulsionou resultados com aquisições recentes, incluindo o laboratório Confiance (25 unidades em Campinas), o LSL em Rio Claro e o Femme, focado em saúde da mulher. A empresa também desistiu de um negócio conjunto com o grupo Porto para comprar participação na Oncoclínicas, citing insufficient time for due diligence, while maintaining its acquisition strategy for future growth.The HinduHow Femme Music helps women artistes find their spaceFemme Music, a record label founded by Sanoli Chowdhury and Vinod Gadher in 2025, launched in India to provide investment, structure, and support for women musicians, building on their 2024 community initiative Indie Grrrl. The label operates through distribution deals and exclusive artist contracts, with sub-labels including Nyima Records, Tala Root Records, and 34 Beat Records, and released Nyima Volume 1, a compilation album featuring 11 female artistes. The label is hosting its first Femme Power live event on June 7 in Bangalore featuring multiple women artistes.Brazil JournalFleury compra o laboratório Femme, com foco na saúde da mulherO Fleury anunciou a aquisição de 100% do Laboratório Femme, focado em saúde da mulher, por R$ 207,5 milhões, com um múltiplo de 0,7x EV/receita e 5,5x EV/EBITDA sobre os números de 2024. O Femme possui 12 unidades, sendo 11 em São Paulo e uma em Osasco, e registrou receita bruta de R$ 286,6 milhões em 2024. Esta é a 22ª aquisição do Fleury desde 2017 e a primeira voltada inteiramente ao segmento feminino, ampliando sua oferta para um público intermediário no portfólio de marcas do grupo.